Mar 31, 2012
The Directors present hereunder the 4th Annual report on the Business
and operations of the Company along with the Audited Statement of
Accounts of the Company for the year ended March 31, 2012. The
financial results for the year are summarized as under:
1. FINANCIAL RESULTS
Amt. in Rupees)
Particulars 2011-121 2010-11
Net Sales and Other Income 4,60,48,351 2,24,47,983
Profit /(Loss) before Interest,
Depreciation and
Taxation (58,42,778) (3,30,94,246)
Less: Interest 17675
Less: Depreciation 98,61,273 1,12,47,374
Net Profit / (Loss) After Tax (1,57,21,726) (4,43,41,620)
Add: Balance bought forward (8,38,91,135) (3,95,49,515)
Balance carried forward to
Balance Sheet (9,96,12,861) (8,38,91,135)
2. PERFORMANCE REVIEW
The net sales and other income of the Company for the financial year
2011-12 stood at Rs. 460.48 Lacs as against previous year Rs. 224.48
Lacs. The Loss after tax is Rs.157.22 Lacs as against Loss after tax of
Rs.443.42 Lacs of corresponding previous year 2010-11.
3. DIVIDEND
Considering the financial performance of the Company for the financial
year ended March 31, 2012, your Directors regret their inability to
recommend dividend on the Equity shares.
4. SUBSIDIARY COMPANY
The Accounts of the wholly owned subsidiary Company, Birla IVF LLP have
been received by the Company and a statement pursuant to Section 212 of
the Companies Act, 1956 forms a part of this Annual Report.
PARTICULARS UNDER SECTION 212 OF THE COMPANIES ACT, 1956
The Ministry of Corporate Affairs, Government of India, vide General
Circular No. 2/2011 dated February 8, 2011, has granted a general
exemption from compliance with Section 212 of the Companies Act, 1956,
subject to fulfillment of conditions stipulated in the circular. The
Company has satisfied the conditions stipulated in the circular and
hence is entitled to the exemption. The financial data of the
subsidiaries have been furnished under 'Annexure I to the
consolidated notes' to financial statement forming part of the Annual
Report. Consolidated Financial Statements of the Company and its
subsidiary for the year ended March 31, 2012, together with reports of
Auditors thereon and the statement pursuant to Section 212 of the
Companies Act, 1956, form part of the Annual Report. The Annual
Accounts and the related detailed information of subsidiary company
will be made available to the Members of the Company and subsidiary
Company seeking such information at any point of time. The Annual
Accounts of the subsidiary Company will also be available for
inspection by any member at the registered/head office of the Company
and that of the subsidiary concerned.
5. DIVERSIFICATION OF BUSINESS
Your Directors thought it prudent to diversify and expand its existing
business portfolio from pure service business to a scalable product
business and need based medical services business such as to set up IVF
Centers, Integrated Wellness Centers, Sports Nutrition etc.
6. MANAGEMENT DISCUSSION AND ANALYSIS REPORT
In terms of clause 49 of the Listing Agreement with the Stock Exchange,
the Management Discussion and Analysis Report is appended to this
report.
7. CORPORATE GOVERNANCE
Your Company will continue to strive to incorporate best of standards
for good corporate governance. As a listed company, all required
measures are being taken to comply with the agreement entered with the
Stock Exchange Guidelines and other statutory regulations. A separate
report on Corporate Governance along with a Certificate of Compliance
from the Auditors forms part of this report.
8. DIRECTORS' RESPONSIBILITY STATEMENT:
Pursuant to the requirement under Section 217 (2AA) of the Companies
Act 1956, with respect to Directors' Responsibility Statement the
Directors of the Company state as under that:-
i. in the preparation of annual accounts, applicable accounting
standards had been followed along with proper explanation relating to
material departure;
ii. the directors had selected such accounting policies and applied
them consistently and made judgments and estimates that are reasonable
and prudent so as to give a true and fair view of the state of affairs
of the Company at the end of the financial year and of the profit or
loss of the Company for that period;
iii. the directors had taken proper and sufficient care for the
maintenance of adequate accounting records in accordance with the
provisions of the Companies Act 1956, for safeguarding the assets of
the Company and for preventing and detecting fraud & other
irregularities;
iv. the directors had prepared the annual accounts on a 'going
concern' basis.
9. DIRECTORS
During the year under review, Shri Ramprakash Murlidhar Mishra was
appointed as an Additional Director of the Company with effect from May
25, 2012. As per provisions of Section 260 of the Companies Act 1956,
such director holds office only upto the date of forthcoming Annual
General Meeting of the Company. The Company has received notice
proposing Shri Ramprakash Murlidhar Mishra as candidate for the office
of Director pursuant to Section 257 of the Companies Act, 1956.
Shri Venkateswarlu Nelabhotla tendered his resignation with effect from
August 9, 2012 as Director of the Company.
Shri Mohandas Shenoy Adige and Shri Anoj Menon Directors of the
Company, retire by rotation and being eligible at the forthcoming
Annual General Meeting, offers themselves for reappointment.
10. PUBLIC DEPOSIT
Your Company has not accepted any fixed deposit from the public. As
such, no amount of principal or interest is outstanding as on the
Balance Sheet date.
11. AUDITORS
M/s. Kanu Doshi Associates, Charter Accountants, the Statutory Auditors
of the Company, retire at the ensuing Annual General Meeting. They
have confirmed their eligibility and willingness for reappointment. The
Directors recommend their reappointment by the Members at the
forthcoming Annual General Meeting.
12. AUDITORS REMARKS
Auditors' Qualification Directors' Explanation
The Auditors have made a remark in point no. 4(vi) of the Auditors'
Report for the year The Board of Directors explanation to this
ended March 31, 2012 which states that the Company has deferred the
accumulated remark is that the management has
revenue expenditure of Rs. 8,97,55,020 (previous period Rs. 5,56,38,638
plus current continued to defer these expenses as it is
period Rs. 3,41,16,382) being in the nature of Brand Building Expenses
which is not in felt that these expenses have benefit off
accordance with of Accounting Standard 26 "Accounting for
Intangibles". Due to the enduring nature to the Company and
above, the loss as reported by the profit and loss account is
understated by Rs. 3,41,16,382 therefore the same shall be written of
in
and reserve of the company is overstated to the extent of Rs.
8,97,55,020. Our report the future years. for the earlier period
contained similar observation
13. PARTICULARS OF CONSERVATION OF ENERGY, TECHNOLOGY ABSORPTION AND
FOREIGN EXCHANGE EARNINGS AND OUTGO
The information relating to energy, technology absorption and foreign
exchange earnings and outgo required to be disclosed under the
Companies (Disclosure of Particulars in the Report of Board of
Directors) Rules, 1988 is given in the Annexure 'A' to the
Directors Report.
14. PARTICULARS OF EMPLOYEES
During the year under review, there was no employee covered under the
provision of Section 2I7(2A) of the Companies Act, 1956 read with the
Companies (Particulars of Employees) Rules, 1975 as amended by
Notification GSR 289(E) dated 3I.03.20II,General Circular No. 23 dated
03.05.2011.
15. HUMAN RESOURCE
Your Directors place on the record their appreciation to the
contribution made by the employees at all levels who, through their
competence, diligence, solidarity, co-operation and support, have
enabled the Company to achieve the desired results during the year.
16. ACKNOWLEDGEMENTS
Your Directors take this opportunity to thank all investors, clients,
vendors, banks, regulatory authorities and wishes to acknowledge the
invaluable support extended to the Company by them. The Directors are
pleased to place on record their appreciation for the valuable
information made by the employees of the Company.
For and on behalf of Board of Directors
Place: Mumbai Dr. Abhijit Desai P.V.R. Murthy
Date: August 9, 2012 Managing Director Director
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article